Nerurkar P V, Park S S, Thomas P E, Nims R W, Lubet R A
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702.
Biochem Pharmacol. 1993 Sep 1;46(5):933-43. doi: 10.1016/0006-2952(93)90504-p.
The cytochrome P450 isozyme specificity for the O-dealkylation of methoxyresorufin (MTR) and benzyloxyresorufin (BZR) in the rat and mouse was investigated. The induction of various alkoxyresorufin O-dealkylation activities was measured in male F344/NCr rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3,4,5,3',4',5'-hexachlorobiphenyl. MTR and ethoxyresorufin (ETR) O-dealkylation activities were induced 30- and 80-fold, respectively, in the liver. ETR O-dealkylation activity was induced > 250-fold in the kidney, whereas the metabolism of MTR was induced only 30-fold in this extrahepatic tissue. Phenacetin, a fairly specific CYP1A2 inhibitor, caused concentration-dependent competitive inhibition of MTR O-dealkylation (ki approximately 20 microM at 0.5 microM substrate) in hepatic microsomes from 3,4,5,3',4',5'-hexachlorobiphenyl-treated rats. The corresponding ki for inhibition of ETR O-dealkylation by phenacetin was > or = 333 microM at a 0.5 microM substrate concentration. A monoclonal antibody displaying inhibitory activity against rat CYP1A1 inhibited ETR O-dealkylation activity, whereas it failed to inhibit MTR O-dealkylation activity. In contrast, a monoclonal antibody reactive with both CYP1A1 and CYP1A2 inhibited both O-dealkylation activities to an equal extent. Similar experiments, employing phenacetin or specific monoclonal antibodies, yielded comparable results when performed with mouse microsomes. The maximal induction of MTR O-dealkylation activity in mice was > 100-fold. The P450 isozyme specificity of BZR O-dealkylation was also examined in both rats and mice. Pregnenolone-alpha-carbonitrile, a strong inducer of CYP3A, only weakly induced BZR O-dealkylation activity. In addition, a monoclonal antibody that specifically inhibits CYP2B caused inhibition of BZR metabolism in microsomes from phenobarbital- or dexamethasone-pretreated rats. In B6C3F1 mice exposed to dietary Aroclor 1254, significant induction of hepatic MTR O-dealkylation activity was observed at concentrations lower than those required for the induction of ETR or BZR O-dealkylation. In summary, it would appear that MTR is a relatively specific substrate for CYP1A2 activity in rodents, while BZR appears to be relatively specific for CYP2B.
研究了大鼠和小鼠中细胞色素P450同工酶对甲氧基试卤灵(MTR)和苄氧基试卤灵(BZR)O-脱烷基化的特异性。在暴露于2,3,7,8-四氯二苯并-p-二恶英或3,4,5,3',4',5'-六氯联苯的雄性F344/NCr大鼠中,测定了各种烷氧基试卤灵O-脱烷基化活性的诱导情况。肝脏中MTR和乙氧基试卤灵(ETR)的O-脱烷基化活性分别诱导了30倍和80倍。肾脏中ETR的O-脱烷基化活性诱导超过250倍,而在这个肝外组织中MTR的代谢仅诱导了30倍。非那西丁是一种相当特异的CYP1A2抑制剂,在来自3,4,5,3',4',5'-六氯联苯处理大鼠的肝微粒体中,它对MTR的O-脱烷基化产生浓度依赖性竞争抑制(在0.5 microM底物时,ki约为20 microM)。在0.5 microM底物浓度下,非那西丁抑制ETR O-脱烷基化的相应ki≥333 microM。一种对大鼠CYP1A1具有抑制活性的单克隆抗体抑制了ETR的O-脱烷基化活性,而未能抑制MTR的O-脱烷基化活性。相反,一种与CYP1A1和CYP1A2都反应的单克隆抗体同等程度地抑制了两种O-脱烷基化活性。用非那西丁或特异性单克隆抗体进行的类似实验,在小鼠微粒体上进行时也得到了类似的结果。小鼠中MTR O-脱烷基化活性的最大诱导超过100倍。还在大鼠和小鼠中研究了BZR O-脱烷基化的P450同工酶特异性。孕烯醇酮-α-腈是CYP3A的强诱导剂,仅微弱诱导BZR的O-脱烷基化活性。此外,一种特异性抑制CYP2B的单克隆抗体在苯巴比妥或地塞米松预处理大鼠的微粒体中抑制了BZR的代谢。在喂食Aroclor 1254的B6C3F1小鼠中,在低于诱导ETR或BZR O-脱烷基化所需浓度时,观察到肝脏MTR O-脱烷基化活性有显著诱导。总之,在啮齿动物中,MTR似乎是CYP1A2活性的相对特异底物,而BZR似乎对CYP2B相对特异。